<DOC>
	<DOCNO>NCT00941486</DOCNO>
	<brief_summary>The objective study evaluate efficacy FST-100 ( 0.1 % dexamethasone ) Ophthalmic Suspension treatment suspect acute adenoviral conjunctivitis .</brief_summary>
	<brief_title>FST-100 Ophthalmic Suspension Acute Adenoviral Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Inclusion</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Conjunctivitis within seven ( 7 ) day initial ocular symptom redness and/or discharge . Clinical suspicion adenoviral etiology . At least three ( 3 ) year age . Subjects guardians capable understand purpose risk study , able give inform consent . Conjunctivitis diagnosis define presence two cardinal sign acute conjunctivitis : 1. conjunctival injection/inflammation , 2. conjunctival discharge/exudates . Conjunctivitis longer 7 day initial ocular symptom . Corneal ulcer , endophthalmitis , confound infection eye . Patients take ocular antiinflammatory medication chronic basis . Active herpes ocular infection . Known suspected pregnancy . Known allergy PVPI . Known allergy dexamethasone . Patients history elevation intraocular pressure result steroid use ( `` steroid responder '' .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>